A Multi-Omics Approach Reveals Features That Permit Robust and Widespread Regulation of IFN-Inducible Antiviral Effectors

The antiviral state, an initial line of defense against viral infection, is established by a set of IFN-stimulated genes (ISGs) encoding antiviral effector proteins. The effector ISGs are transcriptionally regulated by type I IFNs mainly via activation of IFN-stimulated gene factor 3 (ISGF3). In this study, the regulatory elements of effector ISGs were characterized to determine the (epi)genetic features that enable their robust induction by type I IFNs in multiple cell types. We determined the location of regulatory elements, the DNA motifs, the occupancy of ISGF3 subunits (IRF9, STAT1, and STAT2) and other transcription factors, and the chromatin accessibility of 37 effector ISGs in murine dendritic cells. The IFN-stimulated response element (ISRE) and its tripartite version occurred most frequently in the regulatory elements of effector ISGs than in any other tested ISG subsets. Chromatin accessibility at their promoter regions was similar to most other ISGs but higher than at the promoters of inflammation-related cytokines, which were used as a reference gene set. Most effector ISGs (81.1%) had at least one ISGF3 binding region proximal to the transcription start site (TSS), and only a subset of effector ISGs (24.3%) was associated with three or more ISGF3 binding regions. The IRF9 signals were typically higher, and ISRE motifs were “stronger” (more similar to the canonical sequence) in TSS-proximal versus TSS-distal regulatory regions. Moreover, most TSS-proximal regulatory regions were accessible before stimulation in multiple cell types. Our results indicate that “strong” ISRE motifs and universally accessible promoter regions that permit robust, widespread induction are characteristic features of effector ISGs. Key Points Effector IFN-stimulated genes (ISGs) are induced robustly by I-IFNs. Most effector ISGs have at least one TSS-proximal ISGF3 binding region. Promoter regions of effector ISGs are accessible and contain “strong” ISRE motifs.

[1]  T. Decker,et al.  Interferons reshape the 3D conformation and accessibility of macrophage chromatin , 2021, bioRxiv.

[2]  N. Morgan,et al.  An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells , 2020, Nature Communications.

[3]  J. Shendure,et al.  Towards a comprehensive catalogue of validated and target-linked human enhancers , 2020, Nature Reviews Genetics.

[4]  W. Reith,et al.  Specific enhancer selection by IRF3, IRF5 and IRF9 is determined by ISRE half-sites, 5′ and 3′ flanking bases, collaborating transcription factors and the chromatin environment in a combinatorial fashion , 2019, Nucleic acids research.

[5]  J. Schoggins Interferon-Stimulated Genes: What Do They All Do? , 2019, Annual review of virology.

[6]  L. Ivashkiv,et al.  Interferon target-gene expression and epigenomic signatures in health and disease , 2019, Nature Immunology.

[7]  T. Decker,et al.  A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription , 2019, Nature Communications.

[8]  A. Ploss,et al.  Decoding type I and III interferon signalling during viral infection , 2019, Nature Microbiology.

[9]  A. Hoffmann,et al.  Sequential conditioning-stimulation reveals distinct gene- and stimulus-specific effects of Type I and II IFN on human macrophage functions , 2019, Scientific Reports.

[10]  K. Tretina,et al.  Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease , 2019, The Journal of experimental medicine.

[11]  Jason D. Buenrostro,et al.  The cis-Regulatory Atlas of the Mouse Immune System , 2019, Cell.

[12]  Sandy L. Klemm,et al.  Chromatin accessibility and the regulatory epigenome , 2019, Nature Reviews Genetics.

[13]  C. Horvath,et al.  Transcriptional and chromatin regulation in interferon and innate antiviral gene expression. , 2018, Cytokine & growth factor reviews.

[14]  T. Decker,et al.  Regulatory Networks Involving STATs, IRFs, and NFκB in Inflammation , 2018, Front. Immunol..

[15]  K. Sakaguchi,et al.  Interferon stimulation creates chromatin marks and establishes transcriptional memory , 2018, Proceedings of the National Academy of Sciences.

[16]  D. Panne,et al.  Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function , 2017, Proceedings of the National Academy of Sciences.

[17]  Joshua B. Singer,et al.  Fundamental properties of the mammalian innate immune system revealed by multispecies comparison of type I interferon responses , 2017, PLoS biology.

[18]  Eugenia G. Giannopoulou,et al.  Type I IFNs and TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation , 2017, Nature Immunology.

[19]  M. Bulyk,et al.  Transcription factor-DNA binding: beyond binding site motifs. , 2017, Current opinion in genetics & development.

[20]  M. Peppelenbosch,et al.  Transcriptional Regulation of Antiviral Interferon-Stimulated Genes , 2017, Trends in Microbiology.

[21]  T. Decker,et al.  Canonical and Non-Canonical Aspects of JAK–STAT Signaling: Lessons from Interferons for Cytokine Responses , 2017, Front. Immunol..

[22]  Howard Y. Chang,et al.  Lineage-specific and single cell chromatin accessibility charts human hematopoiesis and leukemia evolution , 2016, Nature Genetics.

[23]  G. Cheng,et al.  The Roles of Type I Interferon in Bacterial Infection. , 2016, Cell host & microbe.

[24]  Chun Jimmie Ye,et al.  Parsing the Interferon Transcriptional Network and Its Disease Associations , 2016, Cell.

[25]  C. Glass,et al.  Molecular control of activation and priming in macrophages , 2015, Nature Immunology.

[26]  J. V. Falvo,et al.  A Role for IFITM Proteins in Restriction of Mycobacterium tuberculosis Infection , 2015, Cell reports.

[27]  M. Hersch,et al.  TLR3-Mediated CD8+ Dendritic Cell Activation Is Coupled with Establishment of a Cell-Intrinsic Antiviral State , 2015, The Journal of Immunology.

[28]  G. Stark,et al.  Cooperative Transcriptional Activation of Antimicrobial Genes by STAT and NF-κB Pathways by Concerted Recruitment of the Mediator Complex , 2015, Cell reports.

[29]  Andrew C. Nelson,et al.  Blimp1/Prdm1 Functions in Opposition to Irf1 to Maintain Neonatal Tolerance during Postnatal Intestinal Maturation , 2015, PLoS genetics.

[30]  A. Visel,et al.  Occupancy by key transcription factors is a more accurate predictor of enhancer activity than histone modifications or chromatin accessibility , 2015, Epigenetics & Chromatin.

[31]  G. Natoli,et al.  A dual cis-regulatory code links IRF8 to constitutive and inducible gene expression in macrophages , 2015, Genes & development.

[32]  C. Glass,et al.  The selection and function of cell type-specific enhancers , 2015, Nature Reviews Molecular Cell Biology.

[33]  Howard Y. Chang,et al.  ATAC‐seq: A Method for Assaying Chromatin Accessibility Genome‐Wide , 2015, Current protocols in molecular biology.

[34]  Bin Zhang,et al.  PhosphoSitePlus, 2014: mutations, PTMs and recalibrations , 2014, Nucleic Acids Res..

[35]  C. Rice,et al.  Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.

[36]  J. Stender,et al.  Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. , 2013, Molecular cell.

[37]  David A. Orlando,et al.  Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.

[38]  G. Bejerano,et al.  Enhancers: five essential questions , 2013, Nature Reviews Genetics.

[39]  G. Natoli,et al.  Latent Enhancers Activated by Stimulation in Differentiated Cells , 2013, Cell.

[40]  M. Diamond,et al.  The broad-spectrum antiviral functions of IFIT and IFITM proteins , 2012, Nature Reviews Immunology.

[41]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[42]  M. Mann,et al.  Novel Murine Dendritic Cell Lines: A Powerful Auxiliary Tool for Dendritic Cell Research , 2012, Front. Immun..

[43]  J. MacMicking Interferon-inducible effector mechanisms in cell-autonomous immunity , 2012, Nature Reviews Immunology.

[44]  S. Nutt,et al.  Transcriptional programming of the dendritic cell network , 2012, Nature Reviews Immunology.

[45]  K. Zhao,et al.  Characterization of genome-wide enhancer-promoter interactions reveals co-expression of interacting genes and modes of higher order chromatin organization , 2012, Cell Research.

[46]  J. Ragoussis,et al.  Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-κB family DNA binding , 2011, Nature Immunology.

[47]  C. Rice,et al.  Interferon-stimulated genes and their antiviral effector functions , 2011, Current Opinion in Virology.

[48]  Endre Barta,et al.  Command line analysis of ChIP-seq results , 2011 .

[49]  G. Kochs,et al.  Transcription Factor Redundancy Ensures Induction of the Antiviral State* , 2010, The Journal of Biological Chemistry.

[50]  C. Glass,et al.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.

[51]  Alexander J. Hartemink,et al.  Finding regulatory DNA motifs using alignment-free evolutionary conservation information , 2010, Nucleic acids research.

[52]  David J. Adams,et al.  The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus , 2009, Cell.

[53]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[54]  Bryan R. G. Williams,et al.  Interferon-inducible antiviral effectors , 2008, Nature Reviews Immunology.

[55]  S. Goodbourn,et al.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. , 2008, The Journal of general virology.

[56]  A. Pichlmair,et al.  Innate recognition of viruses. , 2007, Immunity.

[57]  A. Sher,et al.  Cooperation of Toll-like receptor signals in innate immune defence , 2007, Nature Reviews Immunology.

[58]  D. Haussler,et al.  Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. , 2005, Genome research.

[59]  Tak W. Mak,et al.  Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors , 2005, Nature.

[60]  E. Wagner,et al.  AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.

[61]  E. Kremmer,et al.  Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. , 2002, The American journal of pathology.

[62]  Govinda Rao,et al.  IRF3 mediates a TLR3/TLR4-specific antiviral gene program. , 2002, Immunity.

[63]  C. Horvath,et al.  STAT proteins and transcriptional responses to extracellular signals. , 2000, Trends in biochemical sciences.

[64]  T. Taniguchi,et al.  Crystal structure of an IRF‐DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences , 1999, The EMBO journal.

[65]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[66]  T. Taniguchi,et al.  Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system , 1993, Molecular and cellular biology.

[67]  Richard Taylor Interpretation of the Correlation Coefficient: A Basic Review , 1990 .

[68]  J E Darnell,et al.  Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. , 1988, Genes & development.